<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04978077</url>
  </required_header>
  <id_info>
    <org_study_id>2021-01108</org_study_id>
    <nct_id>NCT04978077</nct_id>
  </id_info>
  <brief_title>Networks of Bacterium-Metabolite Interactions in the Small Intestine</brief_title>
  <official_title>Networks of Bacterium-Metabolite Interactions in the Small Intestine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Probands with an Ileo- or Colostomy are assigned to consume a test meal which is either high&#xD;
      in fat or high in carbohydrates. After the test meal samples from the stoma, urine, blood and&#xD;
      skin are retrieved. These will be subjected to large scale analyses of microbiota and&#xD;
      metabolite content. To get a better comparability test subjects will consume a standardized&#xD;
      liquid diet three days before the study day.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Between both study days a two week wash out phase will be done. During the study day sampling&#xD;
      will be done at set time points until 8 hours after the consumption of the test meal.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">July 2024</completion_date>
  <primary_completion_date type="Anticipated">July 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Identification of stimulating and inhibiting metabolite and bacteria interactions</measure>
    <time_frame>8 hours</time_frame>
    <description>Correlation of results of secondary outcome measures to find interactions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reproduction of metabolite-bacteria interactions in vitro culture</measure>
    <time_frame>2 weeks</time_frame>
    <description>By culturing of bacteria with possible interactions together in vitro</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analysis of bacteria species composition</measure>
    <time_frame>8 hours</time_frame>
    <description>by 16S rRNA sequencing of sample content</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cultivation of bacterial strains in various conditions including ileal fluids</measure>
    <time_frame>2 weeks</time_frame>
    <description>Cultivation of native species found in samples, as well as dedicated E. coli with recording capacity for transcriptional changes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolite composition in intestinal fluids</measure>
    <time_frame>8 hours</time_frame>
    <description>by untargeted mass spectrometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolite composition in blood</measure>
    <time_frame>8 hours</time_frame>
    <description>by untargeted mass spectrometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolite composition in urine</measure>
    <time_frame>8 hours</time_frame>
    <description>by untargeted mass spectrometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolite composition in intestinal fluids, blood and urine</measure>
    <time_frame>8 hours</time_frame>
    <description>by untargeted mass spectrometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analyze eucaryotic and viral microbiome composition</measure>
    <time_frame>8 hours</time_frame>
    <description>by shotgun sequencing of sample content</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of microbiota metabolic potential</measure>
    <time_frame>8 hours</time_frame>
    <description>by shotgun sequencing of sample content</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of microbiota metabolic activity</measure>
    <time_frame>8 hours</time_frame>
    <description>by sequencing of transcriptome of sample content</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of microbiota biomass</measure>
    <time_frame>8 hours</time_frame>
    <description>by measuring absolute bacteria counts by flow cytometry of 16S spiking</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">270</enrollment>
  <condition>Diet, Healthy</condition>
  <condition>Microbial Colonization</condition>
  <arm_group>
    <arm_group_label>High fat test meal first, high carbohydrate test meal second</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consumption of a high fat challenge first, consumption of a high carbohydrate challenge after two weeks wash out</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High carbohydrate test meal first, high fat test meal second</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consumption of a high carbohydrate challenge first, consumption of a high fit challenge after two weeks wash out</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Test meal (high fat = Nutricia Calogen®, or high carbohydrate = Nutricia preOp®)</intervention_name>
    <description>After a night fast participants will drink the test meal</description>
    <arm_group_label>High carbohydrate test meal first, high fat test meal second</arm_group_label>
    <arm_group_label>High fat test meal first, high carbohydrate test meal second</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
          -  General good health&#xD;
&#xD;
          -  Ileostomy or colostomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hematologic disorders with contraindication of blood draw&#xD;
&#xD;
          -  Participation in other clinical trial interfering with study protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin Misselwitz, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Clinic for Visceral Surgery and Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Benjamin Misselwitz, Prof. Dr. med.</last_name>
    <phone>31 632 59 00</phone>
    <phone_ext>+41</phone_ext>
    <email>benjamin.misselwitz@dbmr.unibe.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Inselspital</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 12, 2021</study_first_submitted>
  <study_first_submitted_qc>July 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 27, 2021</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Sequencing data will be shared in a public repository</ipd_description>
    <ipd_time_frame>upon publication of study results open ended</ipd_time_frame>
    <ipd_access_criteria>public access</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

